209 related articles for article (PubMed ID: 24788417)
1. Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects.
Di Filippo M; Marçais C; Charrière S; Marmontel O; Broyer M; Delay M; Merlin M; Nollace A; Valéro R; Lagarde M; Pruneta-Deloche V; Moulin P; Sassolas A
PLoS One; 2014; 9(5):e96482. PubMed ID: 24788417
[TBL] [Abstract][Full Text] [Related]
2. Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects.
Di Filippo M; Marçais C; Charrière S; Marmontel O; Broyer M; Delay M; Merlin M; Nollace A; Valéro R; Lagarde M; Pruneta-Deloche V; Moulin P; Sassolas A
PLoS One; 2014; 9(6):e99721. PubMed ID: 24886863
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?
Pruneta V; Autran D; Ponsin G; Marcais C; Duvillard L; Verges B; Berthezene F; Moulin P
J Clin Endocrinol Metab; 2001 Feb; 86(2):797-803. PubMed ID: 11158049
[TBL] [Abstract][Full Text] [Related]
4. Resistance of chylomicron and VLDL remnants to post-heparin lipolysis in ApoE-deficient mice: the role of apoE in lipoprotein lipase-mediated lipolysis in vivo and in vitro.
Zsigmond E; Fuke Y; Li L; Kobayashi K; Chan L
J Lipid Res; 1998 Sep; 39(9):1852-61. PubMed ID: 9741698
[TBL] [Abstract][Full Text] [Related]
5. Reduced lipolysis of large apo E-poor very-low-density lipoprotein subfractions from type IV hypertriglyceridemic subjects in vitro and in vivo.
Evans AJ; Wolfe BM; Strong WL; Huff MW
Metabolism; 1993 Jan; 42(1):105-15. PubMed ID: 8446037
[TBL] [Abstract][Full Text] [Related]
6. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
Murdoch SJ; Breckenridge WC
Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
[TBL] [Abstract][Full Text] [Related]
7. Severe hypertriglyceridemia in a patient heterozygous for a lipoprotein lipase gene allele with two novel missense variants.
Kassner U; Salewsky B; Wühle-Demuth M; Szijarto IA; Grenkowitz T; Binner P; März W; Steinhagen-Thiessen E; Demuth I
Eur J Hum Genet; 2015 Sep; 23(9):1259-61. PubMed ID: 25585702
[TBL] [Abstract][Full Text] [Related]
8. Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride.
Buonuomo PS; Rabacchi C; Macchiaiolo M; Trenti C; Fasano T; Tarugi P; Bartuli A; Bertolini S; Calandra S
J Clin Lipidol; 2017; 11(6):1329-1337.e3. PubMed ID: 28951076
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of lipoprotein lipase induced cholesterol ester accumulation in human hepatoma HepG2 cells.
Cianflone K; Avramoglu RK; Sawyez C; Huff MW
Atherosclerosis; 1996 Feb; 120(1-2):101-14. PubMed ID: 8645351
[TBL] [Abstract][Full Text] [Related]
10. Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: the role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans.
Huff MW; Miller DB; Wolfe BM; Connelly PW; Sawyez CG
J Lipid Res; 1997 Jul; 38(7):1318-33. PubMed ID: 9254059
[TBL] [Abstract][Full Text] [Related]
11. Lipolysis is a prerequisite for lipid accumulation in HepG2 cells induced by large hypertriglyceridemic very low density lipoproteins.
Evans AJ; Sawyez CG; Wolfe BM; Huff MW
J Biol Chem; 1992 May; 267(15):10743-51. PubMed ID: 1587849
[TBL] [Abstract][Full Text] [Related]
12. In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia.
van Barlingen HH; Kock LA; de Man FH; Erkelens DW; de Bruin TW
Atherosclerosis; 1996 Mar; 121(1):75-84. PubMed ID: 8678926
[TBL] [Abstract][Full Text] [Related]
13. The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding.
de Man FH; de Beer F; van der Laarse A; Jansen H; Leuven JA; Souverijn JH; Vroom TF; Schoormans SC; Fruchart JC; Havekes LM; Smelt AH
Atherosclerosis; 2000 Dec; 153(2):363-71. PubMed ID: 11164425
[TBL] [Abstract][Full Text] [Related]
14. Hypertriglyceridemia in Apoa5-/- mice results from reduced amounts of lipoprotein lipase in the capillary lumen.
Yang Y; Beigneux AP; Song W; Nguyen LP; Jung H; Tu Y; Weston TA; Tran CM; Xie K; Yu RG; Tran AP; Miyashita K; Nakajima K; Murakami M; Chen YQ; Zhen EY; Kim JR; Kim PH; Birrane G; Tontonoz P; Ploug M; Konrad RJ; Fong LG; Young SG
J Clin Invest; 2023 Dec; 133(23):. PubMed ID: 37824203
[TBL] [Abstract][Full Text] [Related]
15. Preferential clearance of apoB-48-containing lipoproteins after heparin-induced lipolysis is modulated by lipoprotein lipase activity.
van Beek AP; van Barlingen HH; de Ruijter-Heijstek FC; Jansen H; Erkelens DW; Dallinga-Thie GM; de Bruin TW
J Lipid Res; 1998 Feb; 39(2):322-32. PubMed ID: 9507993
[TBL] [Abstract][Full Text] [Related]
16. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism.
Nikkilä EA; Huttunen JK; Ehnholm C
Diabetes; 1977 Jan; 26(1):11-21. PubMed ID: 187516
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of in vitro lipolysis of human very low-density lipoprotein by lipoprotein lipase.
Schreier L; Berg G; Zago V; Gonzalez AI; Wikinski R
Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):13-8. PubMed ID: 12125224
[TBL] [Abstract][Full Text] [Related]
18. Changes in plasma lipoproteins during lipolysis in vivo in the hypertriglyceridemic state.
Karakas SE; Khilnani S; Divens C; Almario R; Jen KL
Am J Clin Nutr; 1994 Feb; 59(2):378-83. PubMed ID: 8310988
[TBL] [Abstract][Full Text] [Related]
19. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.
Marçais C; Verges B; Charrière S; Pruneta V; Merlin M; Billon S; Perrot L; Drai J; Sassolas A; Pennacchio LA; Fruchart-Najib J; Fruchart JC; Durlach V; Moulin P
J Clin Invest; 2005 Oct; 115(10):2862-9. PubMed ID: 16200213
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.
Medh JD; Fry GL; Bowen SL; Ruben S; Wong H; Chappell DA
J Lipid Res; 2000 Nov; 41(11):1858-71. PubMed ID: 11060356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
